← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

▼ SELL

$ Value

$34K

Shares

1,320

Price

$25

Filed

Feb 4

Insider

Name

Vairavan Latha

Title

SVP Chief Financial Officer

CIK

0002065881

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

63,607

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units ("RSUs"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.745 to $25.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing Info

Accession No.

0001628280-26-005568

Form Type

4

Issuer CIK

0001787306

Vairavan Latha's History

Date Ticker Type Value
2026-03-02 ARQT $70K
2026-03-02 ARQT $2K
2026-02-27 ARQT A $0
2026-02-27 ARQT A $0
2026-02-02 ARQT $34K
2025-11-03 ARQT $2K
2025-08-04 ARQT $1K
2025-05-06 ARQT A $0
2025-05-06 ARQT A $0

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$72K 2026-03-02